Risk factors

MAIA Biotechnology (MAIA) risk factors

Item 1A of every MAIA Biotechnology, Inc. 10-K on file, and what changed from one year to the next.

Open MAIA in Gloomberb →
  • FY2025 10-K risk factors

    79 risks, 16 new, 29 dropped, 27 reworded since the prior year. MAIA added significant risk disclosures regarding its new corporate treasury policy of acquiring and staking digital assets like Solana.

    Filed Mar 23, 2026
  • FY2024 10-K risk factors

    92 risks. MAIA Biotechnology is a clinical-stage biopharmaceutical company dependent on the success of its lead cancer candidate, THIO.

    Filed Mar 21, 2025